Does VORINOSTAT Cause Malignant neoplasm progression? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Malignant neoplasm progression have been filed in association with VORINOSTAT (ZOLINZA). This represents 3.6% of all adverse event reports for VORINOSTAT.
45
Reports of Malignant neoplasm progression with VORINOSTAT
3.6%
of all VORINOSTAT reports
13
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VORINOSTAT?
Of the 45 reports, 13 (28.9%) resulted in death, 6 (13.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORINOSTAT. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does VORINOSTAT Cause?
Febrile neutropenia (177)
Product use in unapproved indication (122)
Thrombocytopenia (89)
Off label use (88)
Anaemia (79)
Sepsis (77)
Diarrhoea (68)
Neutropenia (63)
Nausea (61)
Fatigue (59)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VORINOSTAT Alternatives Have Lower Malignant neoplasm progression Risk?
VORINOSTAT vs VORTIOXETINE
VORINOSTAT vs VORTIOXETINE HYDROBROMIDE
VORINOSTAT vs VOSORITIDE
VORINOSTAT vs VOTRIENT
VORINOSTAT vs VOXELOTOR